Search Within

Gopakumar Vasudeva Iyer

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (36)
  3. Editorial (1)
Groups
  1. Department of Medicine (74)
  2. Genitourinary Oncology Service (74)
  3. Sloan Kettering Institute Postdocs (74)
  4. Solid Tumor Oncology Division (74)
  5. Department of Pathology and Laboratory Medicine (68)
  6. Human Oncology and Pathogenesis Program (68)

More Groups

People
  1. David Solit (64)
  2. Hikmat Al-Ahmadie (58)
  3. Bernard Bochner (47)
  4. Jonathan Rosenberg (44)
  5. Dean Bajorin (39)
  6. Michael Berger (37)

More People

Years
  1. 2025 (5)
  2. 2024 (8)
  3. 2023 (4)
  4. 2022 (11)
  5. 2021 (7)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Cancer Research (7)
  3. Clinical Cancer Research (6)
  4. Urologic Oncology: Seminars and Original Investigations (6)
  5. Laboratory Investigation (5)
  6. Modern Pathology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. American Association for Cancer Research (15)
  3. Nature Publishing Group (14)
  4. Elsevier Inc. (8)
  5. Nature Research (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (74)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Journal Article

    Clinton, T. N.; Chen, Z.; Wise, H.; Lenis, A. T.; Chavan, S.; Donoghue, M. T. A.; Almassi, N.; Chu, C. E.; Dason, S.; Rao, P.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Journal Article

    Warrick, J. I.; Hu, W.; Yamashita, H.; Walter, V.; Shuman, L.; Craig, J. M.; Gellert, L. L.; Castro, M. A. A.; Robertson, A. G.; Kuo, F.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • HER2 as a therapeutic target in bladder cancer
    Meeting Abstract

    Chen, Z.; Tang, X.; Christin, J. R.; Gao, S. P.; Chu, C. E.; Berger, M. F.; Schultz, N. D.; Shen, M. M.; Al-Ahmadie, H. A.; Iyer, G.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization
    Meeting Abstract

    Yip, W.; Kim, K.; Kuo, F.; Lenis, A. T.; Chen, J. F.; Hu, W.; Clinton, T. N.; Chu, C. E.; Almassi, N.; Tracey, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kemel, Y.; De Jesus Escano, M.; Khurram, A.; Reisz, P.; Lenis, A. T.; Goh, A. C.; Cha, E. K.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
    Journal Article

    Tsui, D. W. Y.; Cheng, M. L.; Shady, M.; Yang, J. L.; Stephens, D.; Won, H.; Srinivasan, P.; Huberman, K.; Meng, F.; Jing, X.; more...
    Genome Medicine (2021)

    Fulltext@MSK | Save